TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $541,000 | +33.3% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $406,000 | -20.5% | 7,459 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $511,000 | +10.6% | 7,459 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $462,000 | -30.4% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $664,000 | +17.1% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $567,000 | -47.6% | 7,459 | -40.2% | 0.00% | -20.0% |
| Q2 2019 | $1,083,000 | +49.4% | 12,465 | +49.3% | 0.01% | 0.0% |
| Q4 2018 | $725,000 | +2238.7% | 8,347 | +2682.3% | 0.01% | – |
| Q4 2017 | $31,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | -8.8% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | -66.7% | 300 | -54.5% | 0.00% | -100.0% |
| Q4 2015 | $102,000 | – | 660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |